Yesterday it was reported that the EVP, Engineering of Inogen (INGN), Brenton Taylor, exercised options to buy 18,605 INGN shares at $0.79 a share, for a total transaction value of $14.85K.
Following Brenton Taylor’s last INGN Buy transaction on January 23, 2017, the stock climbed by 59.6%. This recent transaction increases Brenton Taylor’s holding in the company by 55.59% to a total of $6.86 million.
See today’s analyst top recommended stocks >>
Based on Inogen’s latest earnings report for the quarter ending September 30, the company posted quarterly revenue of $95.29 million and quarterly net profit of $16.43 million. In comparison, last year the company earned revenue of $63.79 million and had a GAAP net loss of $606K. INGN’s market cap is $2.67B and the company has a P/E ratio of 67.42. Currently, Inogen has an average volume of 539.2K.
Based on 4 analyst ratings, the analyst consensus is Strong Buy with an average price target of $245.25, reflecting a 99.0% upside. Starting in February 2018, INGN received 24 Buy ratings in a row. Four different firms, including J.P. Morgan and Needham, currently also have a Buy rating on the stock.
The insider sentiment on Inogen has been positive according to 90 insider trades in the past three months. This sentiment is slightly higher than the average sentiment of company insiders in this sector.
Company insider trades are published daily on the SEC (Securities and Exchange Commission). DailyInsider’s proprietary algorithm analyzes these trades and selects the most attractive stocks based on influential insider trades each day. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Inogen, Inc . engages in the development, manufacture, and marketing of portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. Its products consists of Inogen One G4 system, Inogen One G3 system, Inogen One G2 system, and Inogen at Home. The company was founded by Alison Perry, Alison Bauerlein, Brenton Taylor and Byron Myers on November 27, 2001 and is headquartered in Goleta, CA.
